Therefore, we systematically collected and analyzed data from published literature to reveal the relationship between TRIM21 expression and overall survival (OS), progression-free survival (PFS), and clinicopathological features in cancer patients to assess the prognostic value of the possibly new biomarker TRIM21 in diverse types of cancers. The gene discussed is TRIM21; the disease is cancer.